§ 5-19.2-3. Collaborative pharmacy practice.
(a) A pharmacist may engage in collaborative pharmacy practice pursuant to a collaborative practice agreement in accordance with provisions of this chapter or other applicable sections of the regulations. Any pharmacist or physician desiring to engage in collaborate pharmacy practice shall execute a collaborative practice agreement in accordance with regulations promulgated by the department. Each collaborative practice agreement shall set forth at least the following: (1) Site and setting where the collaborative practice is to take place; (2) Informed consent procedures; (3) Qualifications of participating pharmacists and physicians; (4) The role of any employed health care professional with prescriptive privileges participating in the collaborative practice; (5) Scope of conditions or diseases to be managed; (6) Practice protocols; (7) Risk management activities; and (8) Outcomes measurements. Each collaborative practice agreement shall be subject to review and renewal on a biennial basis.
(b) Any pharmacist or physician who deviates from, or practices in a manner inconsistent with, the terms of a collaborative practice agreement shall be in violation of this chapter; such shall constitute grounds for disciplinary action pursuant to this chapter. There shall be no civil liability on the part of, or cause of action of any nature against, a physician or physician's agents or employees for participation in collaborative pharmacy practice as the result of negligence or fault on the part of the pharmacist participating in such collaborative practice agreement.
(P.L. 2001, ch. 68, § 1; P.L. 2009, ch. 310, § 26; P.L. 2016, ch. 64, § 1; P.L. 2016, ch. 72, § 1.)